Previous close | 325.43 |
Open | 327.71 |
Bid | 0.00 x 1200 |
Ask | 0.00 x 800 |
Day's range | 323.75 - 329.43 |
52-week range | 249.98 - 361.41 |
Volume | |
Avg. volume | 1,255,040 |
Market cap | 124.672B |
Beta (5Y monthly) | 0.91 |
PE ratio (TTM) | 39.67 |
EPS (TTM) | 8.26 |
Earnings date | 30 Apr 2024 |
Forward dividend & yield | 3.20 (0.98%) |
Ex-dividend date | 27 Mar 2024 |
1y target est | 372.04 |
Illumina chairman and Hologic CEO Stephen MacMillan is no stranger to dealing with well-known activist investors.
Henry Schein (HSIC) is busy promoting digital workflows for general dentistry and dental specialties.
Investors are optimistic about Chemed (CHE), backed by the strong performance of the VITAS Healthcare and Roto-Rooter segments.